Tel：028-88610620
Email：pr@keymedbio.com/BD@keymedbio.com
Integrate advanced high-throughput screening platforms and leverage hybridoma, in vitro display, and single B cell screening techniques to rapidly discover therapeutic antibody candidates.
Company Profile Management Team Milestones Corporate Culture
R&D Center Pipeline Manufacturing Park Cooperation Expanded Access Policy
Corporate Governance Information Disclosure Financial Reports Stock Information IR Calendar Investor Presentations Email Alerts
Latest News Media
Culture & Benefits
Contact Information Consultation Legal Statement Privacy
Tel：028-88610620
Email：pr@keymedbio.com/BD@keymedbio.com
蜀ICP备2022006281号